• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".对石仓浩的回复。可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299”的评论。
Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.
2
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
3
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式
Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.
4
Detection of Thrombosis Using Soluble C-Type Lectin-like Receptor-2 with D-Dimer Level and Platelet Count.利用可溶性C型凝集素样受体-2结合D-二聚体水平和血小板计数检测血栓形成
J Clin Med. 2024 Oct 8;13(19):5980. doi: 10.3390/jcm13195980.
5
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.
6
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.可溶性C型凝集素样受体2是弥散性血管内凝血的生物标志物。
J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860.
7
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍：可溶性 C 型凝集素样受体 2（sCLEC-2）水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
8
Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction.急性脑梗死患者可溶性C型凝集素样受体2升高
J Clin Med. 2021 Jul 30;10(15):3408. doi: 10.3390/jcm10153408.
9
Measurement of soluble C-type lectin-like receptor 2 in human plasma.人血浆中可溶性C型凝集素样受体2的检测
Platelets. 2015;26(8):711-9. doi: 10.3109/09537104.2015.1021319. Epub 2015 Apr 9.
10
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.C 型凝集素样受体 2 水平与血小板计数比值（C2PAC）升高有助于 IDH 野生型脑胶质瘤术后静脉血栓栓塞症的诊断。
Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21.

引用本文的文献

1
Super Formula for Soluble C-Type Lectin-Like Receptor 2 × D-Dimer in Patients With Acute Cerebral Infarction.可溶性 C 型凝集素样受体 2×D-二聚体在急性脑梗死患者中的超公式。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241232858. doi: 10.1177/10760296241232858.

本文引用的文献

1
What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299.可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对山本等人的评论。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299。
Diagnostics (Basel). 2023 Dec 25;14(1):41. doi: 10.3390/diagnostics14010041.
2
Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2.利用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式
Diagnostics (Basel). 2023 Jul 6;13(13):2299. doi: 10.3390/diagnostics13132299.
3
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.C 型凝集素样受体 2 水平与血小板计数比值（C2PAC）升高有助于 IDH 野生型脑胶质瘤术后静脉血栓栓塞症的诊断。
Thromb Res. 2023 Mar;223:36-43. doi: 10.1016/j.thromres.2023.01.018. Epub 2023 Jan 21.
4
Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019.血浆可溶性C型凝集素样受体2升高与2019冠状病毒病病情恶化相关。
J Clin Med. 2022 Feb 14;11(4):985. doi: 10.3390/jcm11040985.
5
Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count.采用 C2PAC 指数早期识别脓毒症诱导的凝血功能障碍：可溶性 C 型凝集素样受体 2（sCLEC-2）水平与血小板计数的比值。
Platelets. 2022 Aug 18;33(6):935-944. doi: 10.1080/09537104.2021.2019694. Epub 2022 Jan 24.
6
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy.脓毒症诱导的凝血病及国际血栓与止血协会评分系统在新型冠状病毒肺炎相关弥散性血管内凝血中的诊断和预后价值
J Res Med Sci. 2021 Oct 18;26:102. doi: 10.4103/jrms.JRMS_1295_20. eCollection 2021.
7
Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation.可溶性C型凝集素样受体2是弥散性血管内凝血的生物标志物。
J Clin Med. 2021 Jun 28;10(13):2860. doi: 10.3390/jcm10132860.
8
Disseminated intravascular coagulation: epidemiology, biomarkers, and management.弥散性血管内凝血：流行病学、生物标志物和治疗。
Br J Haematol. 2021 Mar;192(5):803-818. doi: 10.1111/bjh.17172. Epub 2021 Feb 8.
9
Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.脓毒症相关性凝血障碍与弥散性血管内凝血。
Semin Thromb Hemost. 2020 Feb;46(1):89-95. doi: 10.1055/s-0039-1694995. Epub 2019 Aug 23.
10
Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI.可溶性 CLEC-2 独立于 ADAM10 产生，并在急性冠状动脉综合征的血浆中增加：与可溶性 GPVI 的比较。
Int J Hematol. 2019 Sep;110(3):285-294. doi: 10.1007/s12185-019-02680-4. Epub 2019 Jun 5.

对石仓浩的回复。可溶性C型凝集素样受体2（sCLEC-2）×D-二聚体/血小板（PLT）（sCLEC-2×D-二聚体/PLT）对凝血/纤溶状态意味着什么？对“山本等人。使用可溶性C型凝集素样受体2诊断弥散性血管内凝血的超级公式。2023年，，2299”的评论。

Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on "Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. 2023, , 2299".

作者信息

Wada Hideo, Yamamoto Akitaka, Shiraki Katsuya, Shimpo Hideto

机构信息

Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.

Department of Emergency and Critical Care Center, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.

出版信息

Diagnostics (Basel). 2023 Dec 25;14(1):42. doi: 10.3390/diagnostics14010042.

DOI:10.3390/diagnostics14010042
PMID:38201352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10795762/
Abstract

We would like to thank Dr. Ishikura for his kind comment [...].

摘要

我们要感谢石仓博士的友好评论[...]。